Related references
Note: Only part of the references are listed.Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Hannah R. Bridges et al.
BIOCHEMICAL JOURNAL (2014)
Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial
Andrea DeCensi et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
The Use of Metformin in Patients with Prostate Cancer and the Risk of Death
Leah Bensimon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Metformin Use and Prostate Cancer Risk
Mark A. Preston et al.
EUROPEAN UROLOGY (2014)
Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)
Christian Rothermundt et al.
EUROPEAN UROLOGY (2014)
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Anila K. Madiraju et al.
NATURE (2014)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
Repurposing biguanides to target energy metabolism for cancer treatment
Michael Pollak
NATURE MEDICINE (2014)
Metformin directly acts on mitochondria to alter cellular bioenergetics
Sylvia Andrzejewski et al.
CANCER & METABOLISM (2014)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin
S. L. Stocker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes
I. Tkac et al.
DIABETES OBESITY & METABOLISM (2013)
Metformin and cancer
Christos V. Rizos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Metformin Use and All-Cause and Prostate Cancer-Specific Mortality Among Men With Diabetes
David Margel et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2013)
Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis
K. Toyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients
Linda Tarasova et al.
PHARMACOGENETICS AND GENOMICS (2012)
Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer
A. J. Colquhoun et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
Isaam Ben Sahra et al.
CANCER RESEARCH (2011)
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo
C. Algire et al.
ONCOGENE (2011)
The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c
Mette M. H. Christensen et al.
PHARMACOGENETICS AND GENOMICS (2011)
Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
Issam Ben Sahra et al.
CANCER RESEARCH (2010)
Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response
Matthijs L. Becker et al.
PHARMACOGENETICS AND GENOMICS (2010)
Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms
Henriette E. Meyer Zu Schwabedissen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin
M. V. Tzvetkov et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study
Matth S. L. Becker et al.
DIABETES (2009)
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus
M. L. Becker et al.
PHARMACOGENOMICS JOURNAL (2009)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
Jing Ma et al.
LANCET ONCOLOGY (2008)
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics
Y. Shu et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
J Müller et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Metformin transport by renal basolateral organic cation transporter hOCT2
N Kimura et al.
PHARMACEUTICAL RESEARCH (2005)
Polyspecific organic cation transporters: their functions and interactions with drugs
H Koepsell
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin
DS Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)